Skip to content

A Randomized Controlled Study on the Treatment of Sacral Canal Cysts With Sacral Canal Reinforcement

A Randomized Controlled Study of Nerve Root Sleeve Reinforcement and Reconstruction and Sacral Canopy for the Treatment of Sacral Canal Cysts

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04465305
Acronym
ARCSTSCC
Enrollment
68
Registered
2020-07-10
Start date
2020-07-01
Completion date
2022-06-30
Last updated
2021-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tarlov Cysts

Keywords

tarlov cysts surgery

Brief summary

The subject will treat 68 patients with symptomatic sacral canal cysts as the research object, and adopt a randomized controlled research method, respectively, using two methods of reinforcement and reconstruction of the nerve root sleeve, sacroplasty and nerve root sleeve plasty, and observed the operation of the patient Complications, preoperative and postoperative short-term and long-term VAS pain scores, JOA neural function scores, and changes in cyst size on imaging examinations, to evaluate the safety of nerve root sleeve reconstruction and sacroplasty in reducing the safety of postoperative cyst recurrence Sex and effectiveness, so as to further improve the surgical treatment of sacral canal cysts, improve the curative effect, and formulate the operation specifications for the treatment of sacral canal cyst

Detailed description

In this subject, a cohort observation method was used to observe 52 patients with two types of surgical removal of hematoma in the basal ganglia under the guidance of frontal ultrasound through keyhole neuroendoscopy and microsurgery for hematoma removal under the guidance of frontal ultrasound. They were divided into endoscopic surgery group and microsurgery. In the endoscopic surgery group, 26 cases were treated with keyhole neuroendoscopy under the guidance of frontal ultrasound for hematoma removal in the basal ganglia area, and 26 cases in the microsurgery group were treated by craniotomy microsurgery hematoma removal surgery. Observe the removal rate of surgical hematoma in the two groups And the safety of the operation and the GCS score, GOS score and MRI examination of nerve fiber damage and postoperative complications at 1 week, 1 month, and 3 months after the operation. Observe and analyze the improvement of the hematoma clearance rate in the endoscopic surgery group. And whether it has an advantage in terms of efficacy

Interventions

PROCEDUREentraped treatment

patients with tarlov cysts treated by entraped and plasty nerve root

PROCEDUREplasty treatment

patients with tarlov cysts treated by plasty nerve root

Sponsors

Beijing Municipal Science & Technology Commission
CollaboratorOTHER
Peking University Third Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Symptomatic nerve root cysts diagnosed by MRI 2. Intact cyst capsule, no defect of sacral canal lamina 3. No other diseases of nervous system, pelvic floor and important organs 4. Agree inclusion

Exclusion criteria

a ) Non-radiculent cysts or asymptomatic cysts b) Cysts cause severe bone erosion to lamina resorption c) Combined with other diseases of nervous system, pelvic floor and important organs d) Disagree to join e) Cannot complete follow-up -

Design outcomes

Primary

MeasureTime frameDescription
recurrent rate of tarlov cysts1 yearpatents who recurrent postoperation

Countries

China

Contacts

Primary Contactliu bin
liubin301@163.com13671027688
Backup Contactwu chao
82267358

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026